Press Releases about Clene Inc
Disruptions in Purine Metabolism Cited in Parkinson’s Development
October 02, 2024
Researchers Identify New Gene Behind ALS Onset
July 29, 2024
BioMedNewsBreaks — Clene Inc. (NASDAQ: CLNN) Announces Upcoming In-Person FDA Meeting to Discuss CNM-Au8
September 16, 2024
Exposures
Product Safety
Does Multiple Sclerosis Reduce Risk of Developing Dementia?
September 11, 2024
UCSF Team Tests New Drug That Could Reverse Multiple Sclerosis
August 19, 2024
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|